Answers are grounded in this paper and cite their sources.
By integrating T2D GWAS from multiple populations, we developed and validated a trans-ancestry PRS, and demonstrated its potential as a meaningful index of risk among diverse patients in clinical settings. Our efforts represent the first step towards the implementation of the T2D PRS into routine healthcare.
No takes yet. Share an insight, caveat, or question.
Ge et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: